A federal judge considered whether pharmaceutical company GlaxoSmithKline can discontinue a life-saving product to avoid Medicaid rebate payments under the Arizona Consumer Fraud Act.
You must log in or # to comment.
A federal judge considered whether pharmaceutical company GlaxoSmithKline can discontinue a life-saving product to avoid Medicaid rebate payments under the Arizona Consumer Fraud Act.